Discover the power of BCR-ABL testing on Bio-Rad's QXDx AutoDG ddPCR System
The QXDx BCR-ABL %IS Kit is the first and only FDA-cleared BCR-ABL test utilizing droplet digital PCR technology.
Learn more about Bio-Rad's BCR-ABL kit for testing on the QXDx ddPCR System.
Contact a Bio-Rad sales representative today.
Thank you. A specialist will contact you shortly.
QXDx BCR-ABL %IS Kit
The best way to assess complete molecular response (CMR) is with a highly sensitive molecular assay. The QXDx BCR-ABL %IS Kit elevates chronic myeloid leukemia (CML) monitoring to a new level of reproducibility and precision with the sensitivity of 0.0028%IS and MR 4.56 with 2 wells. Bio-Rad's BCR-ABL assay delivers a reliable and robust workflow for monitoring chronic myeloid leukemia patients.
The ddPCR Power Advantage
Absolute Quantification
Provides an absolute count of target DNA copies per input sample without the need for standard curves.
Unparalleled Reproducibility
Harnesses the direct quantification of Droplet Digital PCR (ddPCR) and removes the hidden errors created by standard curves.
Unmatched Precision and Sensitivity
Enriched template concentration in target-positive droplets allows for higher precision and sensitivity than real-time PCR.
QXDx AutoDG ddPCR System
- The first and only FDA-cleared ddPCR system
System Includes:
- QXDx Automated Droplet Generator
- QXDx Droplet Reader
QXDx BCR-ABL %IS Kit Workflow
Bio-Rad's Clinical ddPCR Reagents
QXDx AutoDG Consumable Pack
QXDx Droplet Reader Oil
QXDx AutoDG Supermix Pack
(Not required to run QXDx BCR-ABL %IS Kit)